BrainsWay’s TMS Device is Reshaping Brain Disorder Treatments

INN spoke with BrainsWay's Joseph Perekupka about how the company's deep TMS device treats depression and...

March 11th, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Dips 6...

Proteon Therapeutics, Chiasma, Vermillion, Anavex Life Sciences and Foamix Pharmaceuticals were last week's top gainers.

March 10th, 2019

FDA Approves Johnson & Johnson’s Nasal Spray Antidepressant

Spravato, which is administered via a nasal spray, is the first FDA-approved antidepressant in over 30...

March 6th, 2019

Shares of Acerus Pharma Dip Amid Q4 and 2018...

Shares of Acerus Pharmaceuticals dipped 7.14 percent on Tuesday following the release of its Q4 and...

March 5th, 2019

Helius Medical to Expand Globally

CEO Philippe Deschamps says Helius will aim to submit its PoNS device for approval in countries...

March 4th, 2019

Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized...

Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf...

February 28th, 2019

An Investor’s Guide to Multiple Sclerosis

March was dubbed Multiple Scleorsis Awareness Month in 2015 by New Jersey Governor Chris Christie. Here's...

February 28th, 2019

Get the latest Life Science Investing stock information

Get the latest information about companies associated with Life Science Investing Delivered directly to your inbox.

Life Science Investing

Select All
Select None